99 results
IDSA Aspergillosis Treatment
 • Invasive pulmonary aspergillosis (IPA)
 • CNS aspergillosis
 • Cardiac Aspergillus infection
 •
IDSA Aspergillosis ... Treatment • Invasive ... pulmonary aspergillosis ... eye Infectious Diseases ... #pharmacology #IDSA
IDSA Recommended antimicrobial regimens for treatment of patients with Lyme disease.

#Management #InfectiousDiseases #Antibiotics #LymeDisease #Treatment #Regimens
IDSA Recommended ... antimicrobial regimens for treatment ... patients with Lyme disease ... #LymeDisease #Treatment ... #Regimens #IDSA
Hemophilia - Diagnosis and Management
Diagnosis:
 • Consistent bleeding history (unless screening for disease in family members
screening for disease ... in family members ... with established disease ... Individual factor activity ... by a hemophilia treatment
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
Microbiologically Confirmed Pulmonary ... Tuberculosis - IDSA ... #Tuberculosis #ActiveTB ... #pharmacology #IDSA ... #Guidelines #Treatment
Rheumatoid Arthritis - ACR 2021 Guidelines
 - Low Disease Activity
 - Moderate to High Disease Activity
Guidelines - Low Disease ... Activity - Moderate ... to High Disease ... Activity - Methotrexate ... Tapering DMARDs - Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Chronic kidney disease ... • HIV: 2/3 pulmonary ... Tuberculosis Treatment ... Initiating Treatment ... Diagnosis #Management #Treatment
Treatment Algorithm for First Time Pulmonary Embolism
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke,
Treatment Algorithm ... for First Time Pulmonary ... Unprovoked • Active ... #PE #Pulmonary # ... Embolism #Treatment
Pulmonary Hypertension Groups - WHO Classification
Group I - Vascular remodeling of pulmonary arteries
 • Idiopathic, HIV,
Pulmonary Hypertension ... remodeling of pulmonary ... Left-sided heart disease ... , aortic valve disease ... , mitral valve disease
Factors to be considered in deciding to initiate treatment empirically for active tuberculosis (TB) (prior to
deciding to initiate treatment ... empirically for active ... confirmation) #ActiveTB ... initiation #management #IDSA
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Chronic kidney disease ... • HIV: 2/3 pulmonary ... Tuberculosis Treatment ... Initiating Treatment ... Diagnosis #Management #Treatment